TONIX Pharmaceuticals, Inc. to Present at the 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 14, 2012

NEW YORK--(BUSINESS WIRE)--Tonix Pharmaceuticals Holding Corp. (OTCBB:TNXP) (“TONIX” or the “Company”), a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system (“CNS”), including fibromyalgia syndrome (“FM”) and post-traumatic stress disorder (“PTSD”), will be presenting at the 14th Annual Bio CEO & Investor Conference on February 14, 2012, at 8:30 a.m. EST at the Waldorf=Astoria Hotel in New York City.